Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.

In 18 patients with generalised myasthenia treated with oral pyridostigmine, muscular strength, decrement of neuromuscular transmission in the trapezius muscle on repetitive accessory nerve stimulation, and pyridostigmine plasma level were measured repeatedly during 1-3 dosing intervals. Significant...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	J Neurol Neurosurg Psychiatry
Prif Awduron:	Breyer-Pfaff, U, Schmezer, A, Maier, U, Brinkmann, A, Schumm, F
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMJ Publishing Group 1990
Pynciau:	Research Article
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1014211/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2166138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.53.6.502
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!